Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Kedudukan dalam Saham #14517
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Harga Saham
$0.87120957
Modal Pasaran
$405.07M
Perubahan (1 hari)
-0.64%
Perubahan (1 tahun)
57.03%
Negara
SE
Perdagangan Egetis Therapeutics AB (publ) (EGTX)

Kategori

Nisbah P/S bagi Egetis Therapeutics AB (publ) (EGTX)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Egetis Therapeutics AB (publ), nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Egetis Therapeutics AB (publ) dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.95 -
US
12.19 -
NL
3.75 -
AU
24.99 -
US
- -
CH